...
机译:预后营养指数作为治疗切除后肝细胞癌患者的各种炎症的预后评分的预测性更优越
Department of SurgeryHiroshima Red Cross Hospital &
Atomic Bomb Survivors HospitalHiroshima Japan;
Department of SurgeryHiroshima Red Cross Hospital &
Atomic Bomb Survivors HospitalHiroshima Japan;
Department of BiostatisticsYamaguchi University Graduate School of MedicineYamaguchi Japan;
Department of SurgeryHiroshima Red Cross Hospital &
Atomic Bomb Survivors HospitalHiroshima Japan;
Department of Surgery and Science Graduate School of Medical SciencesKyushu UniversityFukuoka Japan;
Department of Surgery and Science Graduate School of Medical SciencesKyushu UniversityFukuoka Japan;
Department of Surgery and Science Graduate School of Medical SciencesKyushu UniversityFukuoka Japan;
Department of Surgery and Science Graduate School of Medical SciencesKyushu UniversityFukuoka Japan;
Department of Surgery and Science Graduate School of Medical SciencesKyushu UniversityFukuoka Japan;
Department of Surgery and Science Graduate School of Medical SciencesKyushu UniversityFukuoka Japan;
Department of Surgery and Science Graduate School of Medical SciencesKyushu UniversityFukuoka Japan;
controlling nutritional status; hepatocellular carcinoma; neutrophil‐to‐lymphocyte ratio; platelet‐to‐lymphocyte ratio; prognostic nutritional index;
机译:预后营养指数作为治疗切除后肝细胞癌患者的各种炎症的预后评分的预测性更优越
机译:一种新颖的基于炎症的预后评分:纤维蛋白原/白蛋白比可预测肝细胞癌根治性切除术后的患者预后
机译:基于炎症的预后评分作为肝癌根治性切除术后肿瘤复发预测指标的比较
机译:基质金属蛋白酶-2和高血管内皮生长因子作为肝细胞癌肝癌患者肝内肿瘤复发的预后标志物,接受放射治疗
机译:基于预后和预测基因特征的亚组分析用于早期非小细胞肺癌患者的辅助化疗
机译:一种基于炎症的新型预后评分:纤维蛋白原/白蛋白比可预测肝细胞癌根治性切除术后的患者预后
机译:同行评论“基于炎症的预后分数”中排名第3预测局部晚期宫颈食管鳞状细胞癌患者接受治疗疗法化学疗法的预后:倾向得分匹配分析(V0.1)“